Opinion|Videos|September 4, 2024
Individualized Management of Central Precocious Puberty
Pediatric endocrinologists explore comprehensive, individualized treatment strategies for Central Precocious Puberty that extend beyond considerations of chronological and bone age.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- When developing an individualized treatment strategy for CPP that goes beyond chronological age and bone age, what should pediatric endocrinologists consider?
- Can you describe the importance of data such as height velocity, bone-age-to-chronological-age ratio, and predicted adult height?
- How do you evaluate patients that are on treatment for CPP?
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves Nuzolvence (zoliflodacin) for treatment of uncomplicated urogenital gonorrhea in 12 years and up
2
Edward Hook, MD, reacts to the FDA approval of zoliflodacin for uncomplicated urogenital gonorrhea
3
Full case: A slender teen with a growing abdomen and shrinking height velocity
4
Meta-analysis finds vegetarian and vegan diets can support healthy growth in children
5
